Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
Add more filters











Publication year range
1.
Am J Dermatopathol ; 44(4): 267-271, 2022 Apr 01.
Article in English | MEDLINE | ID: mdl-34726183

ABSTRACT

ABSTRACT: Although ustekinumab (UST) shows excellent efficacy in treating psoriasis, not all patients have a complete clearance rate. The purpose of this study was to investigate the histopathological characteristics of refractory psoriasis lesions in patients with excellent response to UST. Fifty-seven patients with newly diagnosed psoriasis and 66 patients with a 75% reduction in the Psoriasis Area and Severity Index score after UST treatment were included. Computer-aided image analysis was performed to measure the epidermal thickness, horny layer thickness, number of dermal vessels, and dermal inflammatory cell infiltration rate. Parakeratosis was scored using a 4-point scale. These measurements were compared between the refractory lesions of UST-treated patients and the untreated lesions of newly diagnosed patients after the adjustment for confounding factors. The dermal inflammatory cell infiltration rate was significantly lower in the refractory lesions (P = 0.022). Meanwhile, the epidermal thickness, horny layer thickness, grade of parakeratosis, and dermal vessel count did not differ between the groups (P = 0.125, 0.719, 0.542, and 0.758, respectively). Subgroup analyses were performed within the UST-treated group after dividing them into 2 groups according to the number of treatments or treatment response rates. None of these features were significantly different between the subgroups. This study suggests that the reduction of dermal inflammation by UST was not sufficient to ameliorate the epidermal changes and implies the role of the interleukin-23-independent downstream cytokine pathway in causing the refractory lesions among patients who responded well to UST. The continuation of UST treatment might not further improve epidermal alterations.


Subject(s)
Dermatologic Agents/therapeutic use , Inflammation/chemically induced , Parakeratosis/chemically induced , Psoriasis/drug therapy , Ustekinumab/therapeutic use , Adult , Case-Control Studies , Dermatologic Agents/adverse effects , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Ustekinumab/adverse effects
2.
N Z Med J ; 134(1534): 128-142, 2021 04 30.
Article in English | MEDLINE | ID: mdl-33927445

ABSTRACT

AIM: Granular parakeratosis (GP) is a benign dermatosis characterised by a rash at intertriginous sites. The pathogenesis is uncertain although it is proposed to be an irritant contact reaction with cases related to benzalkonium chloride (BAC) reported. Our experience is that patients often have delayed diagnosis. This study aims to review the clinical presentation and histopathological features of GP. METHODS: This study is a retrospective case series of adult and paediatric patients seen at dermatology clinics in Auckland, New Zealand. Information was collected on patient demographics, presentation, investigations and management. RESULTS: Thirteen cases (seven adults; six children) are included. The typical presentation of GP was erythematous or brown, scaly papules and plaques with desquamation in a predominantly flexural distribution. All patients reported recent exposure to BAC in laundry rinse solution. Nine biopsies were taken from four patients. Psoriasiform and eczematous findings were common on histopathology. The mainstay of treatment was cessation of BAC exposure. CONCLUSION: GP has a distinct clinical pattern although histopathological findings are varied. Clinicians should have a high index of suspicion for GP in patients presenting with erythematous flexural eruptions and seek a history of BAC exposure, especially in the context of the COVID-19 pandemic and increased antiseptic use.


Subject(s)
Benzalkonium Compounds/poisoning , Detergents/poisoning , Parakeratosis/chemically induced , Parakeratosis/diagnosis , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Male , Parakeratosis/pathology , Retrospective Studies
4.
Am J Pathol ; 190(3): 577-585, 2020 03.
Article in English | MEDLINE | ID: mdl-31953037

ABSTRACT

Psoriasis is an autoinflammatory/autoimmune skin disease and the epitome of an exaggerated primary inflammatory response in the surface barrier tissue. Despite the efficacy of dimethyl fumarate, an electrophilic drug for psoriasis management, there is a paucity of mechanistic evidence in vivo. In response to electrophiles, the Kelch-like erythroid cell-derived protein with cap-n-collar homology-associated protein 1/nuclear factor erythroid 2-related factor 2 (NRF2) system mediates a myriad of cytoprotective mechanisms, including the regulation of excessive inflammatory response and epidermal differentiation. Because the psoriasiform tissue reaction comprises neutrophil infiltration and parakeratotic scaling, it is hypothesized that Nrf2 not only regulates inflammatory responses but also maintains epidermal differentiation, a hallmark of epidermal homeostasis. By using the imiquimod-induced cutaneous inflammation model, an exaggerated inflammatory response and impaired epidermal differentiation in Nrf2-/- mice was detected. Dimethyl fumarate treatment in Nrf2+/+ mice attenuated a psoriasiform tissue reaction and rescued epidermal differentiation, which was not observed in Nrf2-/- mice. In accordance with the fact that psoriasis plaques form well-demarcated parakeratotic lesions in association with the psoriasiform tissue reaction, the lesional skin showed reduced expression levels of NRF2 and its downstream target genes compared with nonlesional skin. In conclusion, Nrf2 attenuates the psoriasiform tissue reaction and underscores the mechanistic legitimacy of the electrophile-based approach for the management of psoriasis.


Subject(s)
Imiquimod/adverse effects , Inflammation/pathology , NF-E2-Related Factor 2/metabolism , Parakeratosis/pathology , Psoriasis/pathology , Animals , Cell Differentiation , Cells, Cultured , Chimera , Epidermis/drug effects , Epidermis/pathology , Female , Homeostasis/drug effects , Humans , Immunohistochemistry , Inflammation/chemically induced , Keratinocytes/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-E2-Related Factor 2/genetics , Parakeratosis/chemically induced , Psoriasis/chemically induced , Skin/drug effects , Skin/pathology
5.
Am J Dermatopathol ; 42(10): 756-761, 2020 Oct.
Article in English | MEDLINE | ID: mdl-31567135

ABSTRACT

Aluminum chloride (AlCl3) is the main active ingredient in commonly used antiperspirant. Antiperspirant use may cause a rare keratinization disease, granular parakeratosis (GP), then AlCl3 may be associated with the etiology of GP. The objective of this study is to elucidate the skin effect of topical aluminum application using a mouse model. We sprayed 20% aluminum chloride every day on the depilated mice skin and analyzed the skin clinically, histopathologically, and immunohistologically. We have succeeded in the histological replication of GP on mouse skin. The basophilic granules in the stratum corneum contained filaggrin, and processing of profilaggrin to filaggrin was disrupted in aluminum-treated mouse skin (Al-mouse). In Al-mouse, cytochrome c and cleaved-caspase 3 were upregulated mainly in the granular layer, and caspase 3 p20 subunit was upregulated. TUNEL-positive cells increased significantly in the Al-mouse from the granular to the horny layer. Caspase 3 inhibitor inhibited granular parakeratotic change of Al-mouse. Our results indicated that aluminum-induced apoptosis leads to keratinization arrest and acceleration of nuclear degradation before completion of profilaggrin processing. This could lead to retention of the basophilic granules composed of underprocessed profilaggrin in the horny layer of Al-mouse skin, the hallmark of GP.


Subject(s)
Aluminum Chloride/pharmacology , Antiperspirants/pharmacology , Apoptosis/drug effects , Caspase 3/metabolism , Parakeratosis/chemically induced , Parakeratosis/pathology , Aluminum Chloride/adverse effects , Animals , Antiperspirants/adverse effects , Cytochromes c/metabolism , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Epidermis/metabolism , Epidermis/pathology , Female , Filaggrin Proteins , Immunohistochemistry , Intermediate Filament Proteins/metabolism , Mice, Inbred C57BL , Up-Regulation/drug effects
8.
Skin Pharmacol Physiol ; 30(6): 306-314, 2017.
Article in English | MEDLINE | ID: mdl-29050008

ABSTRACT

BACKGROUND: Vascular changes, both endothelial and functional, are crucial events in inflammatory responses. OBJECTIVES: To investigate the dynamics of endothelial cell (EC) and functional changes during acute inflammation in an in vivo model of the skin using leukotriene B4. METHODS: EC proliferation, vascular network size, vessel diameter (VD), and hypoxia-inducible factor (HIF)-1α were studied by immunohistochemical CD31/Ki67 double staining and single staining of HIF-1α. Cutaneous perfusion (CP) was assessed using the Twente Optical Perfusion Camera. RESULTS: The initial phase illustrated an increase in VD, Ki67+ EC, and HIF-1α expression and late-phase vascular expansion. The HIF-1α and Ki67+ EC expression was limited. CP and VD were augmented after 24 h. CONCLUSION: The early phase of inflammation is characterized by EC proliferation and HIF-1α expression. Vascular expansion continues over time. CP and VD are seen in both phases of inflammation. Angiogenesis, vascular network formation, and perfusion are time-dependent processes which are mutually related during inflammation.


Subject(s)
Leukotriene B4/pharmacology , Skin/drug effects , Administration, Cutaneous , Adult , Cell Proliferation/drug effects , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelium , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Inflammation/chemically induced , Inflammation/metabolism , Laser-Doppler Flowmetry , Male , Middle Aged , Neovascularization, Physiologic , Parakeratosis/chemically induced , Parakeratosis/metabolism , Skin/blood supply , Skin/metabolism , Young Adult
9.
Australas J Dermatol ; 58(3): e138-e140, 2017 Aug.
Article in English | MEDLINE | ID: mdl-27641714

ABSTRACT

Benzalkonium chloride is a quaternary ammonium cationic detergent present in a number of household products, which can act as a major skin irritant. We present the case of six children who developed granular parakeratosis after exposure to benzalkonium chloride in laundry rinse aids, presenting as a brightly erythematous, tender but minimally pruritic, intertriginous eruption followed by superficial desquamation. The eruptions resolved over 3-4 weeks after cessation of exposure.


Subject(s)
Benzalkonium Compounds/adverse effects , Household Products/adverse effects , Parakeratosis/chemically induced , Parakeratosis/pathology , Adolescent , Child , Child, Preschool , Female , Humans , Laundering , Male
11.
Int J Dermatol ; 55(5): e268-74, 2016 May.
Article in English | MEDLINE | ID: mdl-26680344

ABSTRACT

BACKGROUND: Although many cases of cutaneous adverse reactions to imatinib have been reported, their clinical and histopathologic characteristics are not well documented. OBJECTIVES: The present study investigated clinical and histopathologic characteristics of cutaneous adverse reactions to imatinib. METHODS: This retrospective study referred to 46 patients who experienced cutaneous adverse reactions to imatinib. Clinical data including age, sex, skin lesion morphology, underlying disorders, and imatinib treatment parameters (duration of imatinib medication, initial dose, and treatment modifications at the time of the study) were collected. Histopathologic data were available for all patients. RESULTS: Cutaneous adverse reactions to imatinib developed at 1-24 weeks (median onset: 8 weeks) after imatinib administration. The severity of the reaction was categorized as grade 1 in 22%, grade 2 in 41%, and grade 3 in 37% of patients. Onset was earlier in high-severity reactions than in low-severity reactions. The severity of the reaction was dependent on imatinib dose. Grade 3 reactions were noted in nine of 16 (56%) patients administered "high-dose" (600 mg/d) imatinib. Spongiosis (78% of patients) and papillary dermal edema (83% of patients) were common histopathologic findings in the epidermis and dermis, respectively. Lymphohistiocytes were more predominant than eosinophils in dermal inflammatory infiltration. Histopathologic findings did not differ according to dose of imatinib or severity of the reaction. CONCLUSIONS: Although the clinical features of cutaneous adverse reactions to imatinib depend on imatinib dose and the severity of the reaction, histopathologic findings are not associated with these clinical variables.


Subject(s)
Antineoplastic Agents/adverse effects , Drug Eruptions/etiology , Drug Eruptions/pathology , Edema/chemically induced , Imatinib Mesylate/adverse effects , Antineoplastic Agents/administration & dosage , Dose-Response Relationship, Drug , Erythema Multiforme/chemically induced , Female , Humans , Imatinib Mesylate/administration & dosage , Lichenoid Eruptions/chemically induced , Male , Middle Aged , Parakeratosis/chemically induced , Retrospective Studies , Severity of Illness Index , Time Factors
15.
J Dermatol Sci ; 59(3): 176-83, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20688483

ABSTRACT

BACKGROUND: Unsaturated fatty acid from accumulated sebum disrupts calcium influx in keratinocytes and triggers epidermal hyperplasia, leading to comedone formation in the skin. Oleic acid, a representative unsaturated fatty acid, has been shown to be a useful reagent to induce these cellular alternations, however, the detailed mechanism still remains to be elucidated. OBJECTIVES: This study aimed at the identification of the mediator of unsaturated fatty acid-caused epidermal hyperplasia so as to generate the effective therapeutic agents. METHODS: The downstream mediator of oleic acid-treatment was identified in the epidermal keratinocyte and the effect of its antagonistic peptides on the epidermal behaviors was investigated in culture and in vivo. RESULTS: In culture, treatment with oleic acid augmented extracellular secretion of epimorphin in HaCaT keratinocytes and prevented the epidermal terminal differentiation including programmed cell death and cornified envelope formation. The antagonistic peptide of epimorphin (EPn1: a circular compound composed of CGSIEQSC), which was newly generated in this study, restored normal keratinocyte behaviors. In hairless mice, topical application of oleic acid to the dorsal skin caused epidermal hyperplasia with decreased enucleation in the horny layer, which was dramatically hampered by the administration of EPn1. CONCLUSIONS: The effects of unsaturated fatty acid are attributed to the overstimulation of epimorphin signaling and suggest the epimorphin antagonist as a possible therapeutic agent for acne and hyperkeratotic skin disease.


Subject(s)
Membrane Glycoproteins/antagonists & inhibitors , Oleic Acid/adverse effects , Parakeratosis/chemically induced , Parakeratosis/drug therapy , Peptides, Cyclic/therapeutic use , Animals , Apoptosis , Cell Culture Techniques , Cell Differentiation/drug effects , Epidermis/drug effects , Female , Humans , Hyperplasia/drug therapy , Keratinocytes/drug effects , Keratinocytes/metabolism , Membrane Glycoproteins/metabolism , Mice , Mice, Hairless , Peptides, Cyclic/pharmacology
17.
J Cutan Pathol ; 36(3): 355-8, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19220632

ABSTRACT

Necrolytic acral erythema is a newly described entity characterized by sharply demarcated scaly plaques on the dorsum of the hands and feet. More than 30 patients have been reported since 1996, all of whom had anti-hepatitis C virus antibody. A 32-year-old Taiwanese woman had been diagnosed with and treated for systemic lupus erythematosus with lupus nephritis about 10 years earlier. Soon thereafter, she noted several well-demarcated keratotic plaques with erythematous borders on her feet, with sparing of the soles. Histopathology showed diffuse parakeratosis with a neutrophil infiltrate, hypogranulosis, pale upper keratinocytes, scattered and grouped dyskeratotic cells, psoriasiform hyperplasia and a mild lymphocytic infiltrate in the upper dermis. The diagnosis was made after three biopsies. The lesions regularly worsened just before and during menstruation, but patch and intradermal tests for progesterone and estrogen were negative. There was no evidence of either hepatitis B or hepatitis C infection. The lesions did not respond to treatment with zinc. The rash regressed spontaneously when corticosteroids were stopped and recurred when they were restarted, finally resolving completely after she was treated with high-dose pulse steroids for her lupus.


Subject(s)
Erythema/pathology , Hepatitis C , Parakeratosis/pathology , Adult , Asian People , Erythema/chemically induced , Female , Humans , Hyperplasia/chemically induced , Hyperplasia/pathology , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/pathology , Lupus Nephritis/diet therapy , Lupus Nephritis/pathology , Lymphocytes/pathology , Necrosis/chemically induced , Necrosis/pathology , Parakeratosis/chemically induced , Skin/pathology , Steroids/administration & dosage , Steroids/adverse effects , Taiwan
18.
Int J Dermatol ; 47(7): 707-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18613879

ABSTRACT

A healthy 62-year-old woman was referred to our dermatology department with a 1-month history of a pruritic axillary eruption. On examination, multiple erythematous and brownish hyperkeratotic papules were seen in both axillae. Some of these lesions coalesced into plaques, with small areas of sparing, and a background erythematous color was also found in the axillary vaults (Fig. 1). There was no involvement of other intertriginous sites and there were no associated systemic symptoms. The patient was not obese. The patient had removed the hair from her axillae with wax 3 weeks before the development of the eruption. Moreover, she had changed her antiperspirant 1 week before the onset of the lesions. A cutaneous biopsy for histologic analysis was performed. Histologically, the stratum corneum was thickened, with persistent nuclei together with countless small basophilic granules. The granular layer was preserved and, in some areas, hypergranulosis was found (Fig. 2). These findings were characteristic of granular parakeratosis. The cutaneous lesions resolved completely after 1 week of treatment with topical betamethasone dipropionate and gentamicin sulfate (twice daily). The patient was urged to discontinue her use of deodorants.


Subject(s)
Deodorants/adverse effects , Parakeratosis/chemically induced , Parakeratosis/pathology , Administration, Topical , Axilla , Betamethasone/therapeutic use , Biopsy, Needle , Female , Follow-Up Studies , Humans , Immunohistochemistry , Middle Aged , Parakeratosis/drug therapy , Severity of Illness Index , Treatment Outcome
19.
J Am Acad Dermatol ; 58(5 Suppl 1): S84-7, 2008 May.
Article in English | MEDLINE | ID: mdl-18489055

ABSTRACT

Granular parakeratosis is a rare benign dermatosis caused by an acquired disorder of keratinization that usually manifests with reddish-brown keratotic papules and plaques in intertriginous areas. It has specific histologic features but its pathogenesis remains unclear. Its frequency is probably underestimated because the condition is usually misdiagnosed as simple intertrigo. We report herein a new case of granular parakeratosis in a woman treated with liposomal doxorubicin for ovarian carcinoma that showed complete remission after discontinuation of chemotherapy. The relationship between granular parakeratosis and chemotherapy is discussed.


Subject(s)
Antibiotics, Antineoplastic/adverse effects , Doxorubicin/analogs & derivatives , Ovarian Neoplasms/drug therapy , Parakeratosis/chemically induced , Polyethylene Glycols/adverse effects , Doxorubicin/adverse effects , Epidermis/pathology , Female , Humans , Middle Aged , Parakeratosis/pathology
20.
Clin Exp Dermatol ; 33(4): 443-5, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18261136

ABSTRACT

A 40-year-old woman presented with a delusion of warts on the forehead, for which she was applying podophyllin toxin. A skin biopsy was taken, which showed prominent mitotic figures in the basal and suprabasal layers of the epidermis and apoptotic keratinocytes. Histopathologically Bowen's disease was suspected, but was discounted after clinicopathological correlation was obtained and showed absence of epidermal atypia or disorganization. This case demonstrates the histological resemblance of podophyllin reaction to Bowen's disease. Differentiation of self-inflicted from organic skin disease may be difficult, especially where histopathological findings are confounded by cutaneous application of toxins.


Subject(s)
Bowen's Disease/diagnosis , Caustics/adverse effects , Delusions/psychology , Parakeratosis/chemically induced , Podophyllin/adverse effects , Warts/psychology , Adult , Caustics/administration & dosage , Diagnosis, Differential , Female , Humans , Parakeratosis/pathology , Podophyllin/administration & dosage , Scalp Dermatoses/diagnosis , Scalp Dermatoses/psychology , Self Medication , Skin Neoplasms/diagnosis , Skin Neoplasms/psychology , Warts/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL